Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Shares Outstanding (Diluted Average) (2023 - 2025)

Historic Shares Outstanding (Diluted Average) for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $8.9 million.

  • Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) rose 132384.45% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 132384.45%. This contributed to the annual value of $736339.0 for FY2024, which is 919134.38% up from last year.
  • As of Q3 2025, Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) stood at $8.9 million, which was up 132384.45% from $7.3 million recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) registered a high of $10.3 million during Q1 2023, and its lowest value of $7925.0 during Q4 2023.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $3.2 million, with a median of $724190.0 in 2023.
  • Per our database at Business Quant, Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) plummeted by 9972.84% in 2024 and then skyrocketed by 2115522.13% in 2025.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's Shares Outstanding (Diluted Average) (Quarter) stood at $7925.0 in 2023, then soared by 9191.34% to $736339.0 in 2024, then skyrocketed by 1111.78% to $8.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $8.9 million for Q3 2025, versus $7.3 million for Q2 2025 and $5.9 million for Q1 2025.